312 related articles for article (PubMed ID: 2526183)
1. Positively selected Leu-11a (CD16+) cells require the presence of accessory cells or factors for the lysis of herpes simplex virus-infected fibroblasts but not herpes simplex virus-infected Raji.
Fitzgerald-Bocarsly P; Feldman M; Curl S; Schnell J; Denny T
J Immunol; 1989 Aug; 143(4):1318-26. PubMed ID: 2526183
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets.
Fitzgerald PA; Evans R; Kirkpatrick D; Lopez C
J Immunol; 1983 Apr; 130(4):1663-7. PubMed ID: 6601135
[TBL] [Abstract][Full Text] [Related]
3. Natural killer-mediated lysis of some but not all HSV-1- or VSV-infected targets requires the participation of HLA-DR-positive accessory cells.
Howell DM; Fitzgerald-Bocarsly P
Immunology; 1991 Mar; 72(3):443-7. PubMed ID: 1851136
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts.
Oh SH; Bandyopadhyay S; Miller DS; Starr SE
J Immunol; 1987 Oct; 139(8):2799-802. PubMed ID: 2821120
[TBL] [Abstract][Full Text] [Related]
5. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells.
Tilden AB; Cauda R; Grossi CE; Balch CM; Lakeman AD; Whitley RJ
J Immunol; 1986 Jun; 136(11):4243-8. PubMed ID: 3009620
[TBL] [Abstract][Full Text] [Related]
7. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
Yasukawa M; Zarling JM
J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
[TBL] [Abstract][Full Text] [Related]
8. Human natural killer cells limit replication of herpes simplex virus type 1 in vitro.
Fitzgerald PA; Mendelsohn M; Lopez C
J Immunol; 1985 Apr; 134(4):2666-72. PubMed ID: 2982949
[TBL] [Abstract][Full Text] [Related]
9. Alternative mechanisms of natural killer cell activation during herpes simplex virus infection.
Paya CV; Schoon RA; Leibson PJ
J Immunol; 1990 Jun; 144(11):4370-5. PubMed ID: 2160501
[TBL] [Abstract][Full Text] [Related]
10. HLA-restricted lysis of herpes simplex virus-infected monocytes and macrophages mediated by CD4+ and CD8+ T lymphocytes.
Torpey DJ; Lindsley MD; Rinaldo CR
J Immunol; 1989 Feb; 142(4):1325-32. PubMed ID: 2464644
[TBL] [Abstract][Full Text] [Related]
11. Role of interferon in natural kill of HSV-1-infected fibroblasts.
Fitzgerald PA; von Wussow P; Lopez C
J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
[TBL] [Abstract][Full Text] [Related]
12. The human MHC-restricted cellular response to herpes simplex virus type 1 is mediated by CD4+, CD8- T cells and is restricted to the DR region of the MHC complex.
Schmid DS
J Immunol; 1988 May; 140(10):3610-6. PubMed ID: 2834445
[TBL] [Abstract][Full Text] [Related]
13. Lysis of human cytomegalovirus infected fibroblasts by natural killer cells: demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells.
Borysiewicz LK; Rodgers B; Morris S; Graham S; Sissons JG
J Immunol; 1985 Apr; 134(4):2695-701. PubMed ID: 2579152
[TBL] [Abstract][Full Text] [Related]
14. Lysis of herpes simplex virus (HSV) infected targets. IV. HSV-induced change in the effector population.
Hendricks RL; Sugar J
Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):208-13. PubMed ID: 3972502
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 induced non MHC-restricted killing of herpes simplex type-1 (HSV-1) infected allogeneic and autologous lymphoblasts.
Klimpel GR; Asuncion M; Fons M; Norton JD; Albrecht T; Klimpel KD; Stein MD
J Clin Lab Immunol; 1989 May; 29(1):1-7. PubMed ID: 2560794
[TBL] [Abstract][Full Text] [Related]
16. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants.
Bishop GA; Marlin SD; Schwartz SA; Glorioso JC
J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157
[TBL] [Abstract][Full Text] [Related]
17. Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.
Lanier LL; Le AM; Phillips JH; Warner NL; Babcock GF
J Immunol; 1983 Oct; 131(4):1789-96. PubMed ID: 6225799
[TBL] [Abstract][Full Text] [Related]
18. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
Itoh K; Tilden AB; Balch CM
J Immunol; 1986 May; 136(10):3910-5. PubMed ID: 3084648
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells lyse autologous herpes simplex virus infected targets using cytolytic mechanisms distributed clonotypically.
Pietra G; Semino C; Cagnoni F; Boni L; Cangemi G; Frumento G; Melioli G
J Med Virol; 2000 Nov; 62(3):354-63. PubMed ID: 11055246
[TBL] [Abstract][Full Text] [Related]
20. Requirement for HLA-DR+ accessory cells in natural killing of cytomegalovirus-infected fibroblasts.
Bandyopadhyay S; Perussia B; Trinchieri G; Miller DS; Starr SE
J Exp Med; 1986 Jul; 164(1):180-95. PubMed ID: 3014033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]